Replies to post #65750 on Biotech Values

[DewDiligence]

That makes a hat trick! HEB, PP, and INGN—the three stocks I have long listed list in my iHub profile as stocks to avoid owning—each received a Refusal to File letter from the FDA.


<font size=2><font color=red>“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”